NR1H3 and atherosclerosis: The difference in the phenotypes between the myeloid-specific expression of S196A versus our bone marrow transplant model, in which the entire innate and adaptive immune cell compartments express LXRα S196A, suggests that LXRα S196A expression within additional bone marrow-derived cells restrains macrophage proliferation in the plaque to deter atherosclerosis.